Exchange: OTC·Updated 11:18 AM EDT
IOBTQ logo

IOBTQ IO Biotech Inc

$0.00
$0.00
(0.00%)
Today
Mkt Cap$72.00
Vol511.00

About IOBTQ

IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.
50

Neutral Sentiment

How do you feel about IOBTQ?

Advertisement|Remove ads.